CSS LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,500
Closed -$1.57M 1234
2022
Q1
$1.57M Buy
+17,500
New +$1.62M 0.06% 325
2021
Q4
Sell
-15,000
Closed -$1.89M 1332
2021
Q3
$1.89M Buy
+15,000
New +$1.93M 0.08% 257
2021
Q2
Sell
-15,000
Closed -$2.03M 1184
2021
Q1
$2.03M Buy
15,000
+5,000
+50% +$749K 0.08% 227
2020
Q4
$1.41M Sell
10,000
-2,100
-17% -$269K 0.05% 257
2020
Q3
$1.35M Hold
12,100
0.06% 246
2020
Q2
$1.35M Buy
+12,100
New +$1.19M 0.08% 216
2020
Q1
Sell
-15,000
Closed -$1.43M 772
2019
Q4
$1.43M Buy
+15,000
New +$1.3M 0.08% 204

Other funds holding XBI

CSS LLC's XBI Position: Q2 2021 in Review

CSS LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 4,500 shares — an estimated $592K sold.

CSS LLC first reported a position in XBI in Q3 2020 and held it in 2 quarters. The position peaked at $2.67M in Q3 2020. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

  • CSS LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 4,500 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $592K.
  • CSS LLC first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 2 quarters.
  • CSS LLC's State Street SPDR S&P Biotech ETF position peaked at $2.67M in Q3 2020.
  • 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.